Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury
AbstractThe complex pathophysiology of spinal cord injury (SCI) may explain the current lack of an effective therapeutic approach for the regeneration of damaged neuronal cells and the recovery of motor functions. A primary mechanical injury in the spinal cord triggers a cascade of secondary events, which are involved in SCI instauration and progression. The aim of the present review is to provide an overview of the therapeutic neuro-protective and neuro-regenerative approaches, which involve the use of nanofibers as local drug delivery systems. Drugs released by nanofibers aim at preventing the cascade of secondary damage (neuro-protection), whereas nanofibrous structures are intended to re-establish neuronal connectivity through axonal sprouting (neuro-regeneration) promotion, in order to achieve a rapid functional recovery of spinal cord. View Full-Text
Share & Cite This Article
Faccendini, A.; Vigani, B.; Rossi, S.; Sandri, G.; Bonferoni, M.C.; Caramella, C.M.; Ferrari, F. Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury. Pharmaceuticals 2017, 10, 63.
Faccendini A, Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury. Pharmaceuticals. 2017; 10(3):63.Chicago/Turabian Style
Faccendini, Angela; Vigani, Barbara; Rossi, Silvia; Sandri, Giuseppina; Bonferoni, Maria C.; Caramella, Carla M.; Ferrari, Franca. 2017. "Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury." Pharmaceuticals 10, no. 3: 63.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.